Enter to open, tab to navigate, enter to select
NantPharma, LLC acquisition of stock of IgDraSol Inc.
| May 14, 2015 • Private Acquisition Agreements • $90.05 million (subject to earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.